Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …

Atherosclerotic cardiovascular disease and subsequent heart failure threaten global health
and impose a huge economic burden on society. MicroRNA-132 (miR-132), a regulatory …

Alzheimer's disease (AD) is a progressive neuro-degenerative disease characterized by
dementia. MicroRNAs (miRNAs) are involved in many diseases, including AD. MiR-132-3p …

Background Visceral adipose tissue (VAT), which has recently been recognized as an
endocrine organ, contributes to prediabetes and diabetes (T2DM) upon deregulated visceral …

Cardiac fibrosis is a significant global health problem associated with almost all types of
heart disease. Extensive cardiac fibrosis reduces tissue compliance and contributes to …

Recent advances highlight that non-coding RNAs (ncRNAs) are emerging as fundamental
regulators in various physiological as well as pathological processes by regulating macro …

Background Cardiac fibrosis is a common pathological process of most cardiac diseases,
which may result in cardiac function impairment. Long noncoding RNAs (lncRNAs) have …

Emerging evidence has indicated long non‐coding RNAs (lncRNAs) play important roles in
diverse biological processes, including fibrosis. Here, we report that lncRNA H19 is able to …

Cardiac remodeling is a pathophysiological process activated by diverse cardiac stress,
which impairs cardiac function and leads to adverse clinical outcome. This remodeling partly …

Cardiomyopathies encompass a spectrum of heart disorders with diverse causes and
presentations. Fibrosis stands out as a shared hallmark among various cardiomyopathies …